$0.21
2.95%
Downside
Day's Volatility :2.95%
Upside
0.0%
13.62%
Downside
52 Weeks Volatility :99.87%
Upside
99.85%
Period | Endra Life Sciences Inc | Index (Russel 2000) |
---|---|---|
3 Months | -95.41% | 0.0% |
6 Months | -98.4% | 0.0% |
1 Year | -99.6% | 0.0% |
3 Years | -99.99% | -22.2% |
Market Capitalization | 3.9M |
Book Value | $6.21 |
Earnings Per Share (EPS) | -32.0 |
PEG Ratio | 0.0 |
Wall Street Target Price | 10.0 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -60.94% |
Return On Equity TTM | -120.13% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
EBITDA | -9.5M |
Diluted Eps TTM | -32.0 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -11.08 |
EPS Estimate Next Year | -8.91 |
EPS Estimate Current Quarter | -0.07 |
EPS Estimate Next Quarter | -0.04 |
What analysts predicted
Upside of 4661.9%
Sell
Neutral
Buy
Endra Life Sciences Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Endra Life Sciences Inc | -4.55% | -98.4% | -99.6% | -99.99% | -99.98% |
Idexx Laboratories, Inc. | -6.87% | -3.06% | 10.88% | -24.37% | 72.76% |
Agilent Technologies Inc. | 3.98% | 2.57% | 28.99% | -5.75% | 91.3% |
Thermo Fisher Scientific, Inc. | -2.81% | 7.0% | 22.18% | 3.39% | 110.0% |
Danaher Corp. | -2.06% | 12.8% | 28.45% | -10.02% | 94.76% |
Iqvia Holdings Inc. | -4.23% | -0.82% | 15.22% | -7.11% | 56.64% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Endra Life Sciences Inc | NA | NA | 0.0 | -11.08 | -1.2 | -0.61 | NA | 6.21 |
Idexx Laboratories, Inc. | 47.16 | 47.16 | 5.0 | 10.57 | 0.63 | 0.23 | NA | 19.16 |
Agilent Technologies Inc. | 29.96 | 29.96 | 3.08 | 5.24 | 0.25 | 0.08 | 0.01 | 20.53 |
Thermo Fisher Scientific, Inc. | 37.03 | 37.03 | 2.21 | 21.73 | 0.14 | 0.05 | 0.0 | 124.17 |
Danaher Corp. | 49.78 | 49.78 | 2.63 | 7.59 | 0.08 | 0.04 | 0.0 | 68.92 |
Iqvia Holdings Inc. | 29.77 | 29.77 | 1.14 | 11.2 | 0.23 | 0.05 | NA | 36.83 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Endra Life Sciences Inc | Buy | $3.9M | -99.98% | NA | 0.0% |
Idexx Laboratories, Inc. | Buy | $39.2B | 72.76% | 47.16 | 22.34% |
Agilent Technologies Inc. | Buy | $41.3B | 91.3% | 29.96 | 21.75% |
Thermo Fisher Scientific, Inc. | Buy | $228.0B | 110.0% | 37.03 | 14.69% |
Danaher Corp. | Buy | $195.2B | 94.76% | 49.78 | 17.83% |
Iqvia Holdings Inc. | Buy | $42.0B | 56.64% | 29.77 | 9.39% |
Insights on Endra Life Sciences Inc
In the last 1 year, Agilent Technologies Inc. has given 30.1% return, outperforming this stock by 129.7%
In the last 3 years, Endra Life Sciences Inc has experienced a drawdown of -100.0%, however Thermo Fisher Scientific, Inc. resisted the overall trend and outperformed by 94.3%
HRT FINANCIAL LLC
JANE STREET GROUP, LLC
Geode Capital Management, LLC
UBS Group AG
endra life sciences is bringing new capabilities to ultrasound. our photo-acoustic solutions help medical researchers screen and modify disease models with unparalleled quality and speed. we’re proud to have a global installed base of leading institutions using our nexus-128 system, the only 3d imaging solution for imaging anatomy, physiology and labeled molecular targets. the nexus 128 is a preclinical photoacoustic computed tomography (ct) scanner for small animal imaging. the system is used for simple, fast, non-invasive quantification of physiological parameters such as tumor vasculature without ionizing radiation. the fully-3d imaging technology used by the nexus 128 provides increased sensitivity compared to slice-based scanners, and dynamic (4-d) photoacoustic ct scans allow for applications such as quantification of probe uptake. the nexus 128 is currently being used by top imaging laboratories around the globe.
Organization | Endra Life Sciences Inc |
Employees | 21 |
CEO | Mr. Alexander Y. Tokman |
Industry | Health Technology |
Orion Energy Systems Inc
$0.21
-0.48%
Nano Labs Ltd.
$0.21
-0.48%
Innovator Intl Developed Power Buffer Etf - June
$0.21
-0.48%
Bny Mellon Concentrated Intl
$0.21
-0.48%
Fidelity International Multifactor Etf
$0.21
-0.48%
Innovator Us Equity Accelerated Plus Etf - April
$0.21
-0.48%
Amplify Seymour Cannabis Etf
$0.21
-0.48%
Saratoga Investment Corp
$0.21
-0.48%
Ebang International Holdings Inc
$0.21
-0.48%